needle injection News
-
Odin wins INVEST Pitch Perfect Contest
Odin Technologies’ intelligent wearable medical device for diagnosing compartment syndrome won the diagnostics track at the Pitch Perfect startup competition. The track was sponsored by Invetech. Odin Technologies was announced as the winner of the diagnostics startup track at the Pitch Perfect Contest that took place during the MedCity INVEST Conference in Chicago on April 23-24. ...
-
New Multi-pronged Injection Needle Receives CE Mark Approval/ 510k Exempt Status (U.S.)
Conshohocken, PA., September 30, 2003-Rex Medical, L.P., today announced the 510K Exempt Status (U.S.) and CE Mark Approval to market the Quadra-Fuse™ Multi-Pronged Injection Needle designed for the infusion of fluids (chemicals, hypertonic saline, etc.) into soft tissue (liver, other organs, etc.). Quadra-Fuse™ technology is an 18 Gauge stainless steel, multi-pronged ...
-
National drug “take back” program offered in New England communities on Sat. Sept. 25 (CT, ME, MA, NH, RI, VT)
This Saturday, Sept. 25, New Englanders will have the opportunity to safely dispose of unused and unwanted medicines from their homes. On Saturday, more than 3400 sites nationwide will take part in the U.S. Drug Enforcement Administration’s "Take Back" campaign. This is a collaborative effort with state and local government, community, public health and law enforcement partners to collect ...
-
Raising Awareness on the Challenges of Hormone Replacement Injections
The National Transgender Discrimination Survey Report on Health and Health Care recorded at least 80% of transgender people have either taken gender-affirming hormone therapy (GAHT) or want to take GAHT at some point.¹ We sat down to learn from Joelle Jacoski about the drug delivery challenges of taking GAHT. “I came out as non-binary about four months ago and ...
-
Gerresheimer and Portal enter strategic partnership to treat chronically ill patients with innovative needle-free drug-delivery solution
Gerresheimer AG is expanding its portfolio of highly-innovative platform technologies for drug delivery. Gerresheimer, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, today announced an investment into US-based Portal Instruments, a developer of a next-generation needle-free drug delivery technology. Together, the partners aim ...
-
Enesi Pharma’s ImplaVax-Enabled, Solid-Dose Recombinant Classical Swine Fever (CSF) Vaccine Produces Immune Responses Superior to Liquid Vaccine
Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, is delighted to report positive top-line results from a new study evaluating the immune responses generated by an ImplaVax®-enabled unit solid-dose formulation of classical ...
-
Enesi Pharma Achieves Preclinical Proof-of-Concept with ImplaVax-Enabled Pandemic Influenza Vaccine
Innovative needle-free injectable unit solid-dose presentation of recombinant H7N9 pandemic flu vaccine, created using Enesi’s ImplaVax technology, generated immune responses comparable with liquid vaccine and demonstrated excellent thermal stability at temperatures up to 40°C for six months. Enesi Pharma (“Enesi”), an innovative biotechnology company developing ...
-
What to Expect for an Epidural Injection
Roughly 8% of U.S. adults suffer from persistent or chronic back pain. That’s around 65 million people who are prevented from engaging in daily activities. Many are forced to miss days of work due to injury. With rising healthcare costs, many back pain sufferers think that they are left without a real solution, until they try epidural injections. An epidural injection is the infusion of ...
-
Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
Armed Poxvirus selectively destroys tumor cells SAN FRANCISCO and YONGIN, South Korea, January 12, 2009 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), and its South Korean partner Green Cross Corp., today announced treatment of the first five patients in a Phase 2 primary liver cancer clinical trial using its targeted and armed poxvirus JX-594. No significant ...
-
Enesi Pharma Achieves Key Milestone in Development of Thermostable Solid-dose Live Vaccines against Measles and Rubella
Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, announces it has achieved a key milestone in its project to develop needle-free thermostable unit solid-dose live vaccines with retained activity against Measles and Rubella. ...
-
Differences Between Spinal Blocks & Epidurals
The biggest difference between spinal blocks vs epidurals is their amount of pain relief: spinal blocks provide total pain relief, while epidurals provide partial pain relief. The reason for this difference is that the former is an anesthetic, while the latter is an analgesic—no sensation versus no pain. But pain elimination comes with a total lack of feeling in the lower body, due to ...
-
ApiJect Systems Announces Investment by Royalty Pharma and Jefferies
ApiJect Holdings, Inc., the parent company of ApiJect Systems, Corp., a medical technology public-benefit corporation transforming the fill and finish and delivery of injectable vaccines and medicines, announced today that it had completed a $111 million private round of investment. This investment round values ApiJect at approximately $300 million. The new round was led by Royalty Pharma and ...
-
RepliCel Announces Material Patent Milestones
RepliCel Life Sciences Inc. (OTCPK: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing novel, next-generation injection technologies as well as regenerative medicine products in aesthetics and orthopedics, is pleased to announce the filing of a new patent application covering novel aspects of the DermaPrecise™ product portfolio as well ...
-
Possible Side Effects of Local Anesthesia
Small procedures on the body, like a skin biopsy, are great candidates for local anesthesia. An injection or topical cream may be used. If you’ve ever had an injection by a dentist, you’ve had a local anesthetic. Fast-acting, virtually pain-free and convenient, local anesthetics enable much of medicine to occur. Patients can remain awake and leave following their procedure. After ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you